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Background/aim: We aimed to investigate the associations between endothelial nitric oxide synthase (eNOS) gene polymorphisms
[G894T (rs1799983)], intron 4 (27-bpTR) variable number tandem repeat (VNTR) and T786C (rs2070744), and ischemic stroke in the
Anatolian population.
Materials and methods: This case-control study included 112 patients with “stroke of undetermined etiology” and 160 controls. Realtime polymerase chain reaction (RT-PCR) analysis was used to analyze these polymorphisms. Between-group frequencies of alleles and
genotypes were compared using binary logistic regression analysis.
Results: No significant difference was observed between the two groups in terms of the genotype and allele distributions of the
eNOS G894T (rs1799983) polymorphism (P > 0.05). The a alleles and the 4b/a and 4a/a genotypes of the intron 4 (27-bpTR) VNTR
polymorphism had significantly higher frequencies in the patient group than in the control group (OR: 2.715, P < 0.001; OR: 3.396,
P < 0.001; OR: 10.631, P = 0.016, respectively). On the contrary, the TC genotype and C alleles of the T786C (rs2070744) polymorphism
had a significantly lower frequency in the patient group than in the control group (OR: 0.244, P < 0.001, OR: 0.605, P = 0.006, respectively).
Conclusion: Our findings indicate that the eNOS G894T and T786C [rs2070744] polymorphisms are not associated with the risk of
ischemic stroke, whereas the intron 4 [27-bpTR] VNTR may be a risk factor in the Anatolian population.
Keywords: Stroke, polymorphism, endothelial nitric oxide synthase, G894T, variable number tandem repeat, T786C

1. Introduction
According to the WHO, stroke is a clinical syndrome
caused by vascular lesion. It is characterized by rapidly
occurring clinical symptoms and/or signs of focal or
generalized cerebral dysfunction lasting more than 24 h or
resulting in death [1].
Despite improvements in the treatment of acute stroke,
strokes continue to represent the third-leading cause of
death in many countries. Therefore, identification and
prevention of stroke risk factors are gaining increasing
importance. Approximately 70% of stroke risk is attributed
to known etiological risk factors, and genetic factors may
account for a significant proportion among the remaining
unidentified causes [2].
Polymorphisms affecting various genes, such as
angiotensin converting enzyme (ACE), thrombinactivatable fibrinolysis inhibitor (TAFI), and nitric oxide
synthase (NOS) genes, as suggested by recent advances

in genetic research techniques are associated with the
incidence of ischemic stroke (3–9). Nitric oxide (NO), an
enzyme that regulates the endothelial microenvironment
by reducing intracellular calcium levels, inhibits platelet
aggregation and vascular smooth muscle cell proliferation,
and reduces leukocyte adhesion [4,10].
The enzyme NOS catalyzes a reaction whereby
L-arginine is synthesized from the N-terminus of
guanidine. There are two forms of NOS: constitutive
and inducible. Different genes synthesize different
forms of NOS [NOS1 (neuronal NOS), NOS2, and
NOS3 (endothelial NOS)] enzymes [11]. The NOS also
inhibits the oxidation of low-density lipoprotein, thereby
regulating the endothelial microenvironment [4,10]. Thus,
any genetic problem disrupting the amount and structure
of NO will cause an inclination towards clotting.
In some populations, although a significant
relationship was found between the risk of ischemic stroke
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and the polymorphisms of the endothelial NOS (eNOS)
gene (G894T, VNTR, T786C, etc.), studies to determine
whether it may be a risk factor have delivered conflicting
results. Studies in different populations with various
polymorphisms may help determine the risk of stroke
in those populations. We therefore aimed to determine
whether there are significant differences in the G894T
[rs1799983], intron 4 [27-bp TR] VNTR, and T786C
[rs2070744] polymorphisms of the eNOS gene between
stroke patients and healthy individuals in the central
Anatolian population.
2. Materials and methods
2.1. Identification of cases, inclusion and exclusion criteria
To investigate whether there are significant differences in
the distributional frequencies of the G894T (rs1799983),
intron 4 (27-bp TR) VNTR, and T786C (rs2070744)
polymorphisms of eNOS in the central Anatolian
population, we designed two groups: healthy individuals
(control group) and adult stroke patients aged > 18 years. We
included 272 individuals (112 patients and 160 controls) in
the study. Individuals without a history of ischemic stroke
were included in the control group. Patients with ischemic
stroke were classified according to the Trial of Org 10172
in acute stroke treatment (TOAST) classification system,
and those with “stroke of undetermined etiology” and
without any of the exclusion criteria were included in the
patient group. The exclusion criteria are listed in Figure.
We collected blood samples from the control and the
patient groups upon their admission to the neurology
outpatient clinic or emergency department of our hospital.

Figure. The flow chart of the patients.
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We recorded demographic information including
age, sex, medical history, and risk factors for stroke
such as hypertension, coronary artery disease, diabetes,
hyperlipidemia (Table 1). Blood samples obtained from
the patients and the control groups were stored at −80 °C
and subsequently subjected to genetic analysis.
2.2. DNA isolation
We isolated genomic DNA from the blood samples using
the DNA isolation kit (DNeasy Blood & Tissue Kit, Qiagen
GmbH, Hilden, Germany). We checked the purity and
quantity of the extracted DNA by measuring the absorbance
at 260 nm and 280 nm using a spectrophotometer (Nano
Drops spectrophotometer, Thermo Scientific, USA).
2.3. Real-time polymerase chain reaction (RT-PCR) stage
We performed real-time PCR using fluorescence-labeled
TaqMan probes specific for the eNOS G894T [rs1799983],
intron 4 (27-bp TR) VNTR, and T786C (rs2070744)
polymorphisms. We mixed the hybridization solution
(Taq polymerase, reaction buffer, and nucleotide mix),
MgCl2, primers, and probes and genomic DNA so as to
obtain a total volume of 20 μL and transferred them
to a real-time PCR device. We also used positive and
negative controls. After completion of the real-time PCR
amplification, we generated melting curves and then
genotyped eNOS G894T (rs1799983), intron 4 (27-bp TR)
VNTR, and T786C (rs2070744) polymorphisms using an
allelic discrimination assay.
2.4. Statistical analysis
We performed statistical analyses using the SPSS 15.0
(SPSS Inc., Chicago, IL, USA). We determined the mean
and standard deviations of the continuous variables
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and the frequencies and percentages of the categorical
variables. We used the chi-square and Fisher’s exact test
for intergroup comparisons of categorical variables.
We used binary logistic regression analysis to compare
the frequencies of alleles among the patient and control
groups. We used the wild type (of genotypes and alleles) as
a reference for regression analysis. P ≤ 0.05 was considered
statistically significant.
3. Results
The mean age was 68.58 (± 10.848) years in the patient
group and 61.44 (± 8.104) years in the control group.
The patient group comprised 50 (44.6%) females and 62

(55.4%) males, whereas the control group comprised 95
(59.4%) females and 65 (40.6%) males. The demographic
properties and risk factors of the patients have been
presented in Table 1.
3.1. G894T polymorphism
Table 2 presents the genotypes and allele frequencies.
The differences in both genotypes and T alleles were not
statistically significant between the patient and control
groups (Table 2).
3.2. Intron 4 (27-bpTR) VNTR (4b/a) polymorphism
The 4b/a (heterozygous polymorphism) and 4a/a
(homozygous polymorphism) genotypes as well as the

Table 1. Demographic data and the risk factors in patient and control groups.
Patient [n, %]
Age [mean, standard deviation]
Male

Gender

Female

Diabetes mellitus

Control [n, %]

P

χ²

68.58 [± 10.848]

61.44 [± 8.104]

[< 0.05]

85.810

62

65

40.6%

< 0.05

6.779

55.4%

50

44.6%

95

59.4%

< 0.05

6.779

40

35.7%

33

20.6%

< 0.05

8.011
15.785

Hypertension

61

54.5%

47

29.4%

< 0.05

Coronary artery disease

15

13.4%

47

29.4%

< 0.05

11.321

Smoke

9

8%

15

9.4%

NS

1.159

Hyperlipidemia

32

28.6%

19

11.9%

NS

2.449

NS: Nonsignificant
Table 2. Genotype distributions of eNOS G894T [rs1799983], intron 4 [27-bpTR] VNTR, eNOS T786C polymorphisms, and allelic
frequencies in the patient and control groups [binary logistic analysis, wild type is reference for statistical analysis].
Polymorphism
G894T [rs1799983]

Genotype

Allele
intron4 VNTR

Genotype

Allele
T786C

Genotype

Allele

Patient [n, %]

Control [n, %]

P

OR

GG

21 [%18.8]

38 [%23.8]

-

1

GT

77 [%68.8]

103 [%64.4]

0.262

1.440

(0.76-2.77)

TT

14 [%12.5]

19 [%11.9]

0.561

1.313

(0.52-3.29)

G

115 [%39.1]

179 [% 60.9]

-

1

T

109 [%43.8]

140 [%56.2]

0.272

1.211

4b/b

57

[%50.9]

124 [%77.5]

-

1

4b/a

50 [%44.6]

34 [% 21.3]

< 0.0001*

3.396

(1.93-6.08)

4a/a

5

2 [%1.3]

0.016*

10.631

(1.51-215.9)

b

164 [%36.8]

282 [% 63.2]

-

1

a

60 [%61.2]

38 [%38.7]

< 0.0001*

2.715

TT

59

[%52.7]

38 [%23.8]

-

1

TC

35

[%31.2]

103 [% 64.4]

< 0.0001**

0.244

(0.13-0.44)

CC

18

[%16,1]

19 [%11.9]

0.314

0.663

(0.30-1.48)

T

152 [%45.92]

179 [%54.07]

C

72

140 [%66.03]

0.006**

0.605

(0.42-0.86)

[%4.5]

[%33.96]

95% CI

(0.86-1.70)

(1.73-4.26)

*The frequency of 4b/a, 4a/a genotypes and a allele were significantly higher in the patient group than the control group.
**The frequencies of TC genotype and C allele were significantly lower rate in the patient group than the control group.
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a alleles were significantly higher in the patient group
than in the control group (OR: 2.715, 95% Cl: 1.73–4.26,
P < 0.001; OR: 3.396, 95% Cl: 1.93–6.08, P < 0.001; OR:
10.631, 95% Cl: 1.51–215.89, P = 0.016, respectively)
(Table 2).
3.3. T-786C polymorphism
Table 3 also presented the results of the binary logistic
regression analysis. Unlike the first two polymorphisms,
the wild type genotype and allele (TT and T) were found
to be higher in the patient group than in the control group.
The TC genotype and C alleles of the T786C (rs2070744)
polymorphism was significantly less frequent in the
patient group than in the control group (OR: 0.244, 95%
Cl: 0.13–0.44, P < 0.001; OR: 0.605, 95% Cl: 0.42–0.86, P =
0.006, respectively) (Table 2).
4. Discussion
Some studies on eNOS gene polymorphisms (including
G894T, VNTR, and T786C) have suggested that, in some
populations, eNOS is a risk factor for ischemic stroke;
however, few conflicting results have also been reported
[3,4,6,9,10,12–16]. Polymorphisms may play a specific
penetrating role for ethnicity in the sensitivity of ischemic
stroke. We investigated the existence of a relationship
between the G894T (rs1799983), VNTR (4b/a), and
T786C (rs2070744) polymorphisms of the eNOS gene and
ischemic stroke in the central Anatolian population.
4.1. T-786C polymorphism
According to some metaanalyses, no significant differences
exist between the Asian and Caucasian populations in
terms of the T786C genotypes and allele distributions
(Table 3) [6,10]. However, in a contrasting metaanalysis
reported by Wang et al. [17], the predominance of the C
allele of the T-786C polymorphism was highlighted in
Asians, indicating a significant protective effect against the
risk of ischemic stroke in the codominant models (C vs T
for T-786C) (Table 3) [17]. In our study, we also observed

that the C alleles and TC heterozygote polymorphism
genotype were significantly lower in the patient group
(with the possibility of a protective effect) in the Anatolian
population (Tables 2 and 3).
4.2. G894T polymorphism
A significant relationship between the T allele and TT
genotype of the G894T polymorphism and ischemic stroke
risk was found in Asians and north Indians, but not in
Caucasians (Table 4) (3,6,10,17,18). In Morocco, Diakite et
al. reported a significant relationship between the G894T
eNOS polymorphism and ischemic stroke in recessive,
dominant, and codominant models (Table 5) [16].
In a study conducted by Guldiken et al. [19],
the difference in the allelic frequency and genotypic
distribution of the G894T (rs1799983) polymorphism
between the ischemic stroke and the control group in
the Anatolian population was not statistically significant
(Table 4) [19]. This result was similar to our results in the
Anatolian population (Table 4).
4.3. Intron 4 (27-bpTR) VNTR (4b/a)
Some studies have reported a significant relationship
between ischemic stroke and the 4a/a genotype and/or
the 4a allele of intron 4 (27-bpTR) VNTR polymorphism
of the eNOS gene in South India and among the Asian
population, but not in the Caucasian population (Table 5)
[4,6,10,17].
Wang et al. reported a significant relationship between
the 4a allele and the risk of ischemic stroke in dominant
and codominant models in the Chinese population (Table
5) [17].
Yemişçi et al. [20] suggested that, in the Anatolian
population, the 4a/a genotype is protective for isolated
symptomatic lacunar infarction, and this effect is
enhanced in the absence of the T786C polymorphism in
the promoter region. On the contrary, in our study, the
frequency of the 4 a/a and 4b/a genotypes and alleles were
higher in the patient group than in the control group, and

Table 3. Statistical results of studies conducted on enos t786c [rs2070744] polymorphism.
Genotype

Yao YS et al.

Allele

Country (Ethnicity)

TT

TC

CC

T

C

NS

NS

NS

NS

NS

Asian, Caucasian

Guo X

NS

NS

NS

NS

NS

Asian, Caucasian

Wang M et al.

NS

P < 0.05 *

NS

NS

NS

Asian

Our study

NS

< 0.0001*

NS

NS

0.006*

Anatolian

NS: Statistically nonsignificant result. TT, TC, CC: Genotypes of eNOS T786C polymorphism. T and C:
Alleles of eNOS T786C polymorphism.
* The frequency of TC genotype and C allele were significantly lower rate in the patient group than the control
group (protective effect?).
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Table 4. Statistical results of studies conducted on enos g894t polymorphism.
Genotype

Allele

Country (Ethnicity)

GG

GT

TT

G

T

Yao YS et al.

NS

NS

NS

NS

Asians P < 0.05*
Caucasians NS

Asian, Caucasian

Diakite B et al.

NS

P < 0.05*

P < 0.05*

NS

NS

North African

Hong-miao T et al.

NS

NS

P < 0.05*

NS

NS

White, East Asian

Guo

NS

NS

P < 0.05*

NS

Asians P < 0.05*
Caucasians NS

Asian, Caucasian

Kumar A et al.

NS

NS

P < 0.05*

NS

NS

North Indian

Wang M et al.

NS

NS

NS

NS

Asian P < 0.05*

Asian, Caucasian

Guldiken B et al.

NS

NS

NS

NS

NS

Anatolian

Our study

NS

NS

NS

NS

NS

Anatolian

NS: Statistically nonsignificant result. GG, GT, TT: Genotypes of eNOS G894T Polymorphism. G and T: Alleles of
eNOS G894T polymorphism.
*Patients have significantly higher rate than controls.
Table 5. Statistical results of studies conducted on enos intron 4 vntr polymorphism.
Genotype
4b/b

Allele
4b/a

Country (Ethnicity)

4a/a

4b

4a

Munshia A

NS

NS

P < 0.05*

NS

P < 0.05*

Indian

Yao YS et al.

NS

NS

NS

NS

P < 0.05*

Asian, Caucasian

Wang M et al.

NS

NS

NS

NS

Asians P < 0.05*
Caucasians NS

Asian, Caucasian

Guo X

NS

NS

Asians P < 0.05*
Caucasians NS

NS

P < 0.05*

Asian, Caucasian

Yemişçi M.

NS

NS

P < 0.05**

NS

NS

Anatolian

Our study

NS

P < 0.0001*

P: 0.047*

NS

P < 0.0001*

Anatolian

NS: Statistically nonsignificant result. 4b/b, 4b/a, 4a/a: Genotypes of eNOS 4 VTNR polymorphism. 4a and 4b: Alleles of
eNOS 4 VTNR polymorphism.
*Patients have significantly higher rate than controls.
**Patients have significantly lower rate than controls (protective?).

this difference was highly statistically significant. This
contrasting result may be attributed to the inclusion of
only the lacunar infarction group by Yemişçi et al. (Table
5) [20].
Our study is limited by the absence of the evaluation
of body mass index and cholesterol subtypes of patients.
According to the TOAST classification, the incidence
of stroke with an unknown cause is 25%–39% [20]. We
selected only a specific subset of patients and excluded
other causes of stroke, such as atrial fibrillation and

we couldn’t add some important polymorphisms such
as factor V and prothrombin gene polymorphisms for
analysis, because they are not routinely available in our
laboratory.
In conclusion, this is the first study on the eNOS
T786C polymorphism and the second study on the
G894T [rs1799983] and intron 4 VTNR [4a/a] gene
polymorphisms in the Anatolian population. While
no significant relationship exists between the T786C
polymorphism and stroke in Asians and Caucasians,
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we found a significantly low frequency of the T786C
polymorphism (which has a protective effect) in Anatolian
stroke patients, which is similar to that reported by Wang
et al [17]. Guldiken et al. [19], too, found no relationship
between the eNOS G894T [rs1799983] gene polymorphism
and stroke risk in the Anatolian population compared with
the Asian population. We also detected a highly significant
increase in the intron 4 VTNR gene polymorphism in the
stroke patients compared with the Caucasian population.

On this basis, further studies of the normal function of
NO are warranted in terms of primary and secondary
protection against ischemic stroke.
Acknowledgements
The study was approved by the local ethic committee of
Meram Medical Faculty, Ethic approval code: 2015/396.
All participants provided informed consent in the format
required by the relevant authorities and/or boards.

References
11.

Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics,
and prevention. Circulation Research 2017; 120 (3): 472-495. doi:
10.1161/CIRCRESAHA.116.308398.

Sawada T, Kishimoto T, Osaki Y, Okamoto, M, Tahara A et
al. Relation of the Glu298Asp polymorphism of the nitric
oxide synthase gene to hypertension and serum cholesterol in
Japanese workers. Preventive Medicine 2008; 47 (2): 167-171.
doi: 10.1016/j.ypmed.2008.04.006.

12.

3.

Tao HM, Chen GZ. Endothelial NO synthase gene polymorphisms
and risk of ischemic stroke: a meta-analysis. Neuroscience
Research 2009; 64 (3): 311-316. doi: 10.1016/j.neures.2009.04.001

Chen ZQ, Mou RT, Feng DX, Wang Z, Chen G. The role
of nitric oxide in stroke. Medical Gas Research 2017;7 (3): 194203. doi: 10.4103/2045-9912.215750

13.

4.

Munshi A, Rajeshwar K, Kaul S, Chandana E, Shafi G et al.
VNTR polymorphism in intron 4 of the eNOS gene and the
risk of ischemic stroke in a South Indian population. Brain
Research Bulletin 2010; 82 (5-6): 247-250. doi: 10.1016/j.
brainresbull.2010.05.008

Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, controls.
Cell 1994; 78 (6): 915-918. doi: 10.1016/0092-8674(94)90266-6

14.

Djordjevic V, Stankovic M, Brankovic-Sreckovic V, Rakicevic
L, Radojkovic D. Genetic risk factors for arterial ischemic
stroke in children: a possible mthfr and enos gene-gene
interplay? Journal of Child Neurology 2009; 24 (7): 823-827.
doi: 10.1177/0883073808330164.

15.

Song J, Kim OJ, Kim HS, Bae SJ, Hong SP et al. Endothelial
nitric oxide synthase gene polymorphisms and the risk of silent
brain infarction. International Journal of Molecular Medicine
2010; 25 (5): 819-823. doi.org/10.3892/ijmm_00000410

16.

Diakite B, Hamzi K, Slassi I, El Yahyaoui M, El Alaoui MM
et al. G894T endothelial nitric oxide synthase polymorphism
and ischemic stroke in Morocco. Meta Gene 2014; 7: 349-357.
doi: 10.1016/j.mgene.2014.04.003

17.

Wang M, Jiang X, Wu W, Zhang D. Endothelial NO synthase
gene polymorphisms and risk of ischemic stroke in Asian
population: a meta-analysis. PLoS ONE 2013; 8 (3): e60472.
doi:10.1371/journal.pone.0060472

18.

Kumar A, Misra S, Kumar P, Saqar R, Prasad K et al.
Association between Endothelial nitric oxide synthase G894T
gene polymorphism and risk of ischemic stroke in North
Indian population: a case-control study. Neurological Research
2016; 38 (7): 575-579. doi:10.1080/01616412.2016.1181376

1.

Sudlow CL, Warlow CP. Comparing stroke incidence worldwide
what makes studies comparable? Stroke 1996; 27 (3): 550-558.
doi.org/10.1161/01.STR.27.3.550

2.

5.

Ladenvall C, Gils A, Jood K, Blomstrand C, Declerck PJ et al.
Thrombin activatable fibrinolysis inhibitor activation peptide
shows association with all major subtypes of ischemic stroke and
with TAFI gene variation. Arteriosclerosis, Thrombosis,
and Vascular Biology 2007; 27 (4): 955-962. doi:10.1161/01.
ATV.0000259354.93789.

6.

Guo X. Endothelial nitric oxide [eNOS] gene G894T and VNTR
polymorphisms are closely associated with the risk of ischemic
stroke development for Asians: meta-analysis of epidemiological
studies. Molecular Biology Reports 2014; 41 (4): 2571-2583. doi:
10.1007/s11033-014-3115-8

7.

Tokgoz S, Zamani AG, Durakbasi-Dursun HG, Yilmaz O, Ilhan N
et al. TAFI gene polymorphisms in patients with cerebral venous
thrombosis. Acta Neurologica Belgica 2013; 113: 291-297. doi:
10.1007/s13760-012-0170-6

8.

Wei LK, Au A, Menon S, Griffiths LR, Kooi CW et al. Polymorphisms
of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and
ischemic stroke: Meta-analysis. J Stroke Cerebrovasc Dis 2017; 26
(11): 2482-2493. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.048.

9.

Kang MK, Kim OJ, Jeon YJ, Kim HS, Oh SH et al. Interplay
between polymorphisms in the endothelial nitric oxide synthase
[eNOS] gene and metabolic syndrome in determining the risk of
ischemic stroke in Koreans. Journal of the Neurological Sciences
2014; 344 (1): 55-59. doi: 10.1016/j.jns.2014.06.020

19.

Guldiken B, Sipahi T, Guldiken S, Ustundag S, Budak M et
al. Glu298Asp polymorphism of the endothelial nitric oxide
synthase gene in Turkish patients with ischemic stroke.
Molecular Biology Reports 2008; 36 (6): 1539-1543. doi:
10.1007/s11033-008-9348-7

10.

Yao YS, Chang WW, Jin YL, He LP. An updated meta-analysis of
endothelial nitric oxide synthase gene: three well-characterized
polymorphisms with ischemic stroke. Gene 2013; 528 (2): 84-92.
doi: 10.1016/j.gene.2013.06.047.

20.

Yemişçi M, Sinici I, Özkara HA, Hayran M, Ay H et al.
Protective role of 27bp repeat polymorphism in intron 4 of
eNOS gene in lacunar infarction. Free Radical Research 2009;
43 (3): 272-279. doi: 10.1080/10715760802691489

594

